Opendata, web and dolomites

StressEBOV SIGNED

Ebola virus manipulation of the cellular stress responses

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 StressEBOV project word cloud

Explore the words cloud of the StressEBOV project. It provides you a very rough idea of what is the project "StressEBOV" about.

haemorraghic    drugs    firstly    negative    protein    infection    automated    11    strand    characterised    viral    cofactors    live    entire    antiviral    polymerase    mutants    epidemic    treatments    bsl2    acquisition    flow    cas9    pkr    proteins    genome    fundamental    therapeutic    panel    crispr    counteraction    killed    africa    cycle    laboratories    sensing    bsl4    tetracistronic    depletion    sgs    fusion    people    poorly    tested    nonsegmented    causes    trvlp    co    particles    trap    replicated    western    transcription    interaction    microscopy    regulation    latter    bioid2    tagging    proximity    image    ebov    virus    interactome    life    inhibits    vp35biotin    filovirus    validated    vp35    replication    proteomic    cytoplasmic    trvlps    sensors    ebola    genetic    fever    competent    cellular    rna    approved    ligase    transcribed    trigger    reverse    severe    stress    unknown    rig    gfp    imagestream    granule    overexpression    knockout    cytometric    vaccines    limited    pathogenic    biochemical    rnas    secondly    sg    summary    counteract    treatment    purification    cell    candidate   

Project "StressEBOV" data sheet

The following table provides information about the project.

Coordinator
KING'S COLLEGE LONDON 

Organization address
address: STRAND
city: LONDON
postcode: WC2R 2LS
website: www.kcl.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website https://www.kcl.ac.uk/lsm/research/divisions/diiid/departments/infectious/research/neil/lab1
 Total cost 183˙454 €
 EC max contribution 183˙454 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-04-01   to  2019-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KING'S COLLEGE LONDON UK (LONDON) coordinator 183˙454.00

Map

 Project objective

Ebola virus (EBOV) is a highly pathogenic filovirus that causes severe haemorraghic fever and killed over 11,000 people during the recent epidemic in Western Africa. Although potential vaccines and drugs are being tested, no treatment has been approved. Therefore, understanding the cellular regulation of EBOV replication is fundamental to develop novel treatments. EBOV is a nonsegmented negative-strand RNA virus for which research is limited to BSL4 laboratories. However, a recent reverse genetic system using tetracistronic transcription- and replication-competent virus-like particles (trVLPs) allows modelling of the entire EBOV life cycle under BSL2 conditions. The EBOV genome is transcribed and replicated by the viral polymerase complex but the regulation of these processes remains poorly characterised. EBOV RNAs can also trigger antiviral responses via cytoplasmic RNA-sensors RIG-I and PKR, the latter also promoting stress granule (SG) formation. While EBOV inhibits RNA-sensing, the impact of SGs on EBOV is unknown. Therefore, I will investigate the role of cellular stress responses on EBOV replication and their potential counteraction by the EBOV VP35 protein using the trVLP system. Firstly, I will analyse the impact of SGs on EBOV replication by overexpression and CRISPR/Cas9 depletion of SG proteins. Using a panel of VP35 mutants, I will also investigate its potential to counteract SGs by automated flow cytometric image acquisition (Imagestream). Secondly, I will identify the EBOV polymerase complex interactome during infection using two distinct proteomic approaches: co-purification with a VP35-GFP fusion protein(GFP-trap) and VP35biotin-ligase proximity tagging (BioID2). Candidate VP35 cofactors will be validated by biochemical interaction, CRISPR-knockout and live cell microscopy to determine their role in EBOV replication. In summary, this project will increase the understanding of EBOV replication and identify new therapeutic targets.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "STRESSEBOV" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "STRESSEBOV" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

CLIMACY (2020)

Practices of Climate Diplomacy and Uneven Policy Responses on Climate Change on Human Mobility

Read More  

DIGILEAD (2020)

Digital leadership, well-being and performance in organizations

Read More  

Photonic Radar (2019)

Implementation of Long Reach Hybrid Photonic Radar System and convergence over FSO and PON Networks

Read More